243 related articles for article (PubMed ID: 18819875)
1. [Ginsenoside Rg1 modulates COX-2 expression in the substantia nigra of mice with MPTP-induced Parkinson disease through the P38 signaling pathway].
Wang Q; Zheng H; Zhang ZF; Zhang YX
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1594-8. PubMed ID: 18819875
[TBL] [Abstract][Full Text] [Related]
2. [Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease].
Wang YS; Zhou JP; Wei ZF; Tian QY; Zhou HX; Zhang YX
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1199-202, 1205. PubMed ID: 17715026
[TBL] [Abstract][Full Text] [Related]
3. [Effect of phosphorylated-ERK1/2 on inducible nitric oxide synthase expression in the substantia nigra of mice with MPTP-induced Parkinson disease].
Shi C; Zhang YX; Zhang ZF
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):60-3. PubMed ID: 19218114
[TBL] [Abstract][Full Text] [Related]
4. [P38 MAPK signaling pathway regulates nuclear factor-κB and inducible nitric oxide synthase expressions in the substantia nigra in a mouse model of Parkinson's disease].
Wang Q; Zhang H; Liu M; Zhang Z; Wei Z; Sun N; Mao T; Zhang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1176-80. PubMed ID: 25176090
[TBL] [Abstract][Full Text] [Related]
5. [Possible mechanisms of the protective effect of ginsenoside Rg1 on apoptosis in substantia nigra neurons].
Chen Y; Chen XC
Yao Xue Xue Bao; 2002 Apr; 37(4):249-52. PubMed ID: 12579817
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress.
Chen XC; Zhou YC; Chen Y; Zhu YG; Fang F; Chen LM
Acta Pharmacol Sin; 2005 Jan; 26(1):56-62. PubMed ID: 15659115
[TBL] [Abstract][Full Text] [Related]
8. [P38MAPK pathway regulates COX-2 and caspase-3 expression in a mouse model of Parkinson disease].
Wei ZF; Wang YS; Ma LR; Wang Q; Zhang ZF; Zhang YX
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2010-3, 2017. PubMed ID: 19861252
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of ginsenoside Rg1 against MPTP-induced apoptosis in mouse substantia nigra neurons.
Chen XC; Chen Y; Zhu YG; Fang F; Chen LM
Acta Pharmacol Sin; 2002 Sep; 23(9):829-34. PubMed ID: 12230953
[TBL] [Abstract][Full Text] [Related]
10. [Protective effects of Cistanche total glycosides on dopaminergic neuron in substantia nigra of model mice of Parkinson's disease].
Li WW; Yang R; Cai DF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Mar; 28(3):248-51. PubMed ID: 18476428
[TBL] [Abstract][Full Text] [Related]
11. Effect of Zishenpingchan granule prepared from Chinese medicinal substances on the c-Jun N-terminal protein kinase pathway in mice with Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Ye Q; Yuan X; Zhou J; Yuan C; Yang X
J Tradit Chin Med; 2017 Apr; 37(2):244-51. PubMed ID: 29960635
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg1 Ameliorates Motor Function in an Animal Model of Parkinson's Disease.
Jiang W; Wang Z; Jiang Y; Lu M; Li X
Pharmacology; 2015; 96(1-2):25-31. PubMed ID: 26065578
[TBL] [Abstract][Full Text] [Related]
13. [The protective effect of ginsenoside Rg1 on dopaminergic neurons of substantia in the ovariectomized rat model of Parkinson's disease].
Xu L; Liu LX; Chen WF; Xie JX; Huang WX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):1-5. PubMed ID: 21141541
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra.
Sun XC; Ren XF; Chen L; Gao XQ; Xie JX; Chen WF
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):94-103. PubMed ID: 26455404
[TBL] [Abstract][Full Text] [Related]
15. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.
Boyd JD; Jang H; Shepherd KR; Faherty C; Slack S; Jiao Y; Smeyne RJ
Brain Res; 2007 Oct; 1175():107-16. PubMed ID: 17884023
[TBL] [Abstract][Full Text] [Related]
16. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not elicit long-lasting increases in cyclooxygenase-2 expression in dopaminergic neurons of monkeys.
Vázquez-Claverie M; Garrido-Gil P; San Sebastián W; Belzunegui S; Izal-Azcárate A; López B; Marcilla I; Luquin MR
J Neuropathol Exp Neurol; 2009 Jan; 68(1):26-36. PubMed ID: 19104449
[TBL] [Abstract][Full Text] [Related]
17. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
Kubo K; Inada T; Shingu K
Brain Res; 2011 Apr; 1387():125-33. PubMed ID: 21376018
[TBL] [Abstract][Full Text] [Related]
18. TLR4 signaling mediates AP-1 activation in an MPTP-induced mouse model of Parkinson's disease.
Zhao XD; Wang FX; Cao WF; Zhang YH; Li Y
Int Immunopharmacol; 2016 Mar; 32():96-102. PubMed ID: 26803521
[TBL] [Abstract][Full Text] [Related]
19. Possible mechanisms of the protection of ginsenoside Re against MPTP-induced apoptosis in substantia nigra neurons of Parkinson's disease mouse model.
Xu BB; Liu CQ; Gao X; Zhang WQ; Wang SW; Cao YL
J Asian Nat Prod Res; 2005 Jun; 7(3):215-24. PubMed ID: 15621629
[TBL] [Abstract][Full Text] [Related]
20. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z
J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
